Tacrolimus-induced reversible posterior leukoencephalopathy syndrome in a child with nephrotic syndrome: a case report
BackgroundTacrolimus is widely used as an immunosuppressant in the management of refractory nephrotic syndrome. Although effective, it may occasionally lead to rare but serious adverse effects such as posterior reversible leukoencephalopathy syndrome (PRES). PRES has traditionally been associated wi...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-01-01
|
| Col·lecció: | Frontiers in Pediatrics |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fped.2026.1690215/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|